Evidence map›Paper›PMID 25318673›Full record

ArticleMolecular biology of the cell2014

VWA domain of S5a restricts the ability to bind ubiquitin and Ubl to the 26S proteasome.

Ravit Piterman, Ilana Braunstein, Elada Isakov, Tamar Ziv, Ami Navon, Shenhav Cohen, Ariel Stanhill

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ravit PitermanDepartment of Biochemistry, Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel.
Ilana BraunsteinDepartment of Biochemistry, Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel.
Elada IsakovDepartment of Biochemistry, Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel.
Tamar ZivSmoler Proteomics Center, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Ami NavonDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Shenhav CohenDepartment of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Ariel StanhillDepartment of Biochemistry, Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel stanhill@tx.technion.ac.il.
Technion – Israel Institute of Technology · ILWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 26S proteasome recognizes a vast number of ubiquitin-dependent degradation signals linked to various substrates. This recognition is mediated mainly by the stoichiometric proteasomal resident ubiquitin receptors S5a and Rpn13, which harbor ubiquitin-binding domains. Regulatory steps in substrate binding, processing, and subsequent downstream proteolytic events by these receptors are poorly understood. Here we demonstrate that mammalian S5a is present in proteasome-bound and free states. S5a is required for efficient proteasomal degradation of polyubiquitinated substrates and the recruitment of ubiquitin-like (Ubl) harboring proteins; however, S5a-mediated ubiquitin and Ubl binding occurs only on the proteasome itself. We identify the VWA domain of S5a as a domain that limits ubiquitin and Ubl binding to occur only upon proteasomal association. Multiubiquitination events within the VWA domain can further regulate S5a association. Our results provide a molecular explanation to how ubiquitin and Ubl binding to S5a is restricted to the 26S proteasome.

Indexed as

Activating Transcription Factor 4Amino Acid SequenceAnimalsHEK293 CellsHumansMaleMiceMolecular Sequence DataPolyubiquitinProteasome Endopeptidase ComplexProtein BindingProtein Interaction Domains and MotifsProteolysisRNA-Binding ProteinsUbiquitinUbiquitinated ProteinsActivating Transcription Factor 4ATF4 protein, humanATP dependent 26S proteasePolyubiquitinProteasome Endopeptidase ComplexPSMD4 protein, humanRNA-Binding ProteinsUbiquitinUbiquitinated Proteins

Identifiers

PMID25318673
PMCPMC4263443
OpenAlexW2141223333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.